Amlodipine induced gingival hyperplasia: A rare entity

International Journal of Cardiology

Volumn 122, Issue 3, 2007, Pages

  Bhatia, Vineet ^a   Mittal, Ajay ^a   Parida, Ashok K ^a   Talwar, Rajesh ^a   Kaul, Upendra ^a  

^a FORTIS HOSPITAL   (India)

Author keywords

Amlodipine; Gingival hyperplasia

Indexed keywords

AMLODIPINE; ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; IMMUNOSUPPRESSIVE AGENT; RAMIPRIL;

ADULT; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GINGIVA HYPERPLASIA; HUMAN; HYPERTENSION; MALE; MOUTH HYGIENE; PRIORITY JOURNAL; RISK FACTOR;

AMLODIPINE; GINGIVAL HYPERPLASIA; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ORAL HYGIENE;

EID: 35348975022     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.066     Document Type: Article

References (6)

1. Matharu M.S., Van Vilet J.A., Ferrari M.D., and Goadsby P.J. Verapamil induced gingival enlargement in cluster headache. J Neural Neurosurg Psychiatry 76 (2005) 124-127
2. Ellis J.S., Seymour R.A., Steele J.G., et al. Prevalence of gingival overgrowth induced by calcium channel blockers: a community based study. J Periodontol 70 1 (1999) 63-67
3. Miller C.S., and Damm D.D. Incidence of verapamil induced gingival hyperplasia in a dental population. J Periodontal 63 (1992) 453-456
4. Jorgensen M.G. Prevalence of amlodipine gingival hyperplasia. J Periodontol 68 7 (1997) 676-678
5. Pernu H.E., Oikarinen K., Hietanen J., et al. Verapamil-induced gingival overgrowth: a clinical, histologic, and biochemical approach. J Oral Pathol Med 18 (1989) 422-425
6. Camargo P.M., Melnick P.R., Pirih F.Q., et al. Treatment of drug-induced gingival enlargement: aesthetic and functional considerations. Periodontology 27 (2000) 131-138